Coronavirus (COVID-19) common operating—28 October 2021. Australian Government Department of Health (2021)
Omicron variant in confirmed NSW cases—28 November 2021. NSW Ministry of Health (2021)
Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Global Challenges. 2017;1(1):33–46.
Au J, Bull R, Deveson I, Foster C, Rawlinson W, Ruiz Silva M, Van Hal S, Royal Prince Alfred Hospital MR. Accession ID EPI_ISL_6814922, EPI_ISL_6814923. GISAID. 2021.
Visontay E. Australia Covid update: Omicron variant spreading rapidly as NSW and Victoria cases grow. Guardian Australia. 2021.
Liu B, Stepien S, Pye V, Law C, Dalton C, Durrheim DN, Macartney K. High attack rate of SARS-CoV-2 b.1.1.529 among two-dose vaccinated populations in two indoor entertainment setting outbreaks. J Infect Dis. 2022. https://doi.org/10.1093/infdis/jiac184
Hodcroft EB. CoVariants: SARS-CoV-2 Mutations and Variants of Interest. 2021.
NSW Patient Flow Systems Program (PFS). NSW Ministry of Health. 2021.
Grosso FM, Presanis AM, Kunzmann K, Jackson C, Corbella A, Grasselli G, Andreassi A, Bodina A, Gramegna M, Castaldi S, et al. Decreasing hospital burden of COVID-19 during the first wave in Regione Lombardia: an emergency measures context. BMC Public Health. 2021;21(1):1–9.
Presanis AM, Kunzmann K, Grosso FM, Jackson CH, Corbella A, Grasselli G, Salmoiraghi M, Gramegna M, Angelis DD, Cereda D. Risk factors associated with severe hospital burden of COVID-19 disease in regione lombardia: a cohort study. BMC Infect Dis. 2021; 21(1) . https://doi.org/10.1186/s12879-021-06750-z
Vekaria B, Overton C, Wiśniowski A, Ahmad S, Aparicio-Castro A, Curran-Sebastian J, Eddleston J, Hanley NA, House T, Kim J, et al. Hospital length of stay for COVID-19 patients: data-driven methods for forward planning. BMC Infect Dis. 2021;21(1):1–15.
Jackson CH, Tom BD, Kirwan PD, Mandal S, Seaman SR, Kunzmann K, Presanis AM, Angelis DD. A comparison of two frameworks for multi-state modelling, applied to outcomes after hospital admissions with COVID-19. Stat Methods Med Res. 2022; 096228022211067. https://doi.org/10.1177/09622802221106720
Larson MG, Dinse GE. A mixture model for the regression analysis of competing risks data. Appl Stat. 1985;34(3):201. https://doi.org/10.2307/2347464.
Jackson C. flexsurv: A platform for parametric survival modeling in R. J Stat Softw. 2016; 70(8). https://doi.org/10.18637/jss.v070.i08
R Core Team: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria (2021). R Foundation for Statistical Computing. https://www.R-project.org/
Delignette-Muller ML, Dutang C. fitdistrplus: an R package for fitting distributions. Journal of statistical software. 2015;64:1–34.
Liu B, Spokes P, He W, Kaldor J. High risk groups for severe covid-19 in a whole of population cohort in australia. BMC Infect Dis. 2021;21(1):685. https://doi.org/10.1186/s12879-021-06378-z.
Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, Ghamande S, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Shapiro NI, Gibbs KW, Files DC, Hager DN, Shehu A, Prekker ME, Erickson HL, Exline MC, Gong MN, Mohamed A, Henning DJ, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Khan A, Hough CL,Busse LW, ten Lohuis CC, Duggal A, Wilson JG, Gordon AJ, Qadir N, Chang SY, Mallow C, Rivas C, Babcock HM, Kwon JH, Halasa N, Chappell JD, Lauring AS, Grijalva CG, Rice TW, Jones ID, Stubblefield WB, Baughman A, Womack KN, Rhoads JP, Lindsell CJ, Hart KW, Zhu Y, Olson SM, Kobayashi M, Verani JR, Patel MM. Influenza, in the Acutely Ill (IVY) Network, O.V.: Association Between mRNA Vaccination and COVID-19 Hospitalization and DiseaseSeverity. JAMA 2021;326(20): 2043–2054. https://doi.org/10.1001/jama.2021.19499
Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B. Characteristics and outcomes of hospitalized patients in south africa during the COVID-19 omicron wave compared with previous waves. JAMA. 2022;327(6):583. https://doi.org/10.1001/jama.2021.24868.
Christensen PA, Olsen RJ, Long SW, Snehal R, Davis JJ, Saavedra MO, Reppond K, Shyer MN, Cambric J, Gadd R, Thakur RM, Batajoo A, Mangham R, Pena S, Trinh T, Kinskey JC, Williams G, Olson R, Gollihar J, Musser JM. Signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with coronavirus disease 2019 caused by the omicron variant of severe acute respiratory syndrome coronavirus 2 in houston, texas. Am J Pathol. 2022. https://doi.org/10.1016/j.ajpath.2022.01.007.
Peralta-Santos A, Rodrigues EF, Moreno J, Ricoca V, Casaca P, Fernandes E, Gomes JP, Ferreira R, Isidro J, Pinto M, Borges V, Vieira L, Duarte S, Sousa C, Almeida JP, Menezes L, Ferreira BI, Matias, A, Pelerito A, Freire S, Grilo T, Borges CM, Moutinho V, Leite A, Kislaya I, Rodrigues AP, Leite PP, Nunes B. Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with delta (b.1.617.2). SSRN Electron J. 2022. https://doi.org/10.2139/ssrn.4017381
Voinsky I, Baristaite G, Gurwitz D. Effects of age and sex on recovery from COVID-19: analysis of 5769 israeli patients. J Infect. 2020;81(2):102–3. https://doi.org/10.1016/j.jinf.2020.05.026.
Warrillow S, Austin D, Cheung W, Close E, Holley A, Horgan B, Jansen M, Joynt G, Lister P, Moodie S, et al. ANZICS guiding principles for complex decision making during the COVID-19 pandemic. Crit Care Resuscit. 2020;22(2):98–102.
Sigal A. Milder disease with Omicron: is it the virus or the pre-existing immunity? Nat Rev Immunol. 2022; 1–3.
Ward IL, Bermingham C, Ayoubkhani D, Gethings, OJ, Pouwels, KB, Yates T, Khunti K, Hippisley-Cox J, Banerjee A, Walker AS, Nafilyan V. Risk of covid-19 related deaths for SARS-CoV-2 omicron (b.1.1.529) compared with delta (b.1.617.2): retrospective cohort study. BMJ. 2022;070695. https://doi.org/10.1136/bmj-2022-070695
Varney J, Bean N, Mackay M. The self-regulating nature of occupancy in ICUs: stochastic homoeostasis. Health Care Manage Sci. 2019;22(4):615–34.
Baltas I, Boshier FAT, Williams CA, Bayzid N, Cotic M, Guerra-Assunção JA, Irish-Tavares D, Haque T, Hart J, Roy S, Williams R, Breuer J, Mahungu TW. Post-vaccination coronavirus disease 2019: A case–control study and genomic analysis of 119 breakthrough infections in partially vaccinated individuals. Clin Infect Dis. 2021. https://doi.org/10.1093/cid/ciab714.
Foster C, Jean T, Wong M, Yeang M, Van Hal S, Rawlinson W. Serology, Virology Division (SAViD), N.S.W.H.P.R.: Accession ID EPI_ISL_12666310. GISAID (2022)
COVID-19 treatments. Australian Government Department of Health (2022). https://www.health.gov.au/health-alerts/covid-19/treatments/about. Accessed 30 Aug 2022.
Razonable RR, Pawlowski C, O’Horo JC, Arndt LL, Arndt R, Bierle DM, Borgen MD, Hanson SN, Hedin MC, Lenehan P, Puranik A, Seville MT, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan A, Wilker CG, Badley AD, Ganesh R. Casirivimab-imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19. EClinicalMedicine. 2021;40: 101102. https://doi.org/10.1016/j.eclinm.2021.101102.
Eimer J, Vesterbacka J, Svensson A-K, Stojanovic B, Wagrell C, Sönnerborg A, Nowak P. Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study. J Intern Med. 2020;289(3):434–6. https://doi.org/10.1111/joim.13162.
Tatham L, Sharp J, Kijak E, Herriott J, Neary M, Box H, Valentijn A, Cox H, Pertinez H, Curley P, Arshad U, Rajoli RK, Rannard S, Stewart J, Owen A. Lack of ronapreve (REGN-CoV casirivimab and imdevimab) virological efficacy against the SARS-CoV-2 omicron variant (b.1.1.529) in k18-hACE2 mice. 2022. https://doi.org/10.1101/2022.01.23.477397
Australian Government, D.o.H., Aged Care, T.G.A.: Shortages of tocilizumab (Actemra) medicines. www.tga.gov.au/news/safety-alerts/shortages-tocilizumab-actemra-medicines. 2022.
COVID-19 cases datasets, NSW COVID-19 cases data. NSW Ministry of Health, Data.NSW. 2022.
NSW Notifiable Conditions Information Management System (NCIMS). NSW Ministry of Health. 2022.